Agenas

Name

Agenas

Legal name

Agenzia Nazionale per i servizi sanitari Regionali

Website

https://agenas.gov.it

Company type

Private

Founded year

1993

Operating status

Operating

Headcount range

251–500 employees

Ownership category

akta.pro rank

Product category

Government Healthcare Services

NAICS

Administration of Public Health Programs (923120)

SIC

Services-Health Services (8000)

akta.pro primary industry

Geriatric, Frailty & Fall-Prevention Remote Monitoring (HLALAFAI)

Keywords

• Healthcare coordination services
• National health monitoring
• Health technology assessment
• Digital health platforms
• Clinical outcomes evaluation

Headquarters

HQ city

Roma, Lazio

HQ country

Italy

HQ region

Europe

Offices2 records

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Technology or R&D, Operations, Infrastructure

Revenue model

1. Government Funding: AGENAS is a national government agency funded by the Italian Ministry of Health. The agency receives public funding to support regional health services, conduct research, develop digital platforms, and implement national health programs including PNRR (Piano Nazionale di Ripresa e Resilienza) initiatives.

Go-to-market motion3 records

Distribution channels5 records

Marketing channels12 records

Core offering

AGENAS is the Italian National Agency for Regional Health Services, providing national-level coordination, monitoring, evaluation, and digital platform services for the Italian National Health Service (SSN). It operates proprietary digital platforms including the National Waiting Lists Platform (PNLA), National Outcomes Program (PNE), MIA AI clinical decision support, telemedicine infrastructure, and the Electronic Health Record (FSE), while conducting Health Technology Assessment and IRCCS research coordination across 21 Italian regions.

Differentiator

Problem solved

Functional benefit

Brands

• MIA - AGENAS: AI platform project (MIA - Machine Intelligence Assistant) for artificial intelligence support to primary healthcare, part of PNRR Mission 6 Health Component 1.
• Agenzia per la Sanità Digitale

Products and services

• Piattaforma Nazionale delle Liste di Attesa (PNLA) National platform for monitoring healthcare appointment waiting times, providing citizens and regions with transparency on scheduling performance across priority classes (Urgent, Breve, Differita, Programmed). Tracks 14.9 million appointments in H1 2026 across 21 Italian regions.
• PNE - Programma Nazionale Esiti (National Outcomes Program) National Outcomes Program - a clinical and organizational audit support tool covering hospital care, territorial care, and equity indicators. Used by Italian regional health authorities to evaluate healthcare quality and outcomes across the national health system.
• MIA - AGENAS AI Platform (Machine Intelligence Assistant) Artificial intelligence platform developed under PNRR Mission 6 for healthcare professionals providing diagnostic suggestions, chronic disease management, prevention support, and evidence-based clinical decision support through text-based interaction with verifiable sources.
• Piattaforma Nazionale di Telemedicina (PNT) National Telemedicine Platform monitoring Televisita, Teleconsulto, Telemonitoraggio/Telecontrollo, and Teleassistenza services with machine learning-based predictive analysis for national telemedicine service oversight.
• MIA Lab - AI Training Program Training program for healthcare professionals to learn and adopt the MIA AI platform, consisting of asynchronous learning modules, live virtual classrooms, video tutorials, and support materials.
• Ricerca Corrente Agenas 2025-2027 Research Program Triennial research program involving 55 IRCCS institutes (25 public, 30 private) to strengthen quality assessment, innovation, and IRCCS network collaboration through four project lines, supporting hospital-based biomedical and clinical research.
• Accreditamento (Accreditation Services) National accreditation support services for regional healthcare facilities, providing standardized quality and safety oversight across Italy's decentralized health system.
• Health Technology Assessment (HTA) and Horizon Scanning Services National HTA evaluation and Horizon Scanning services for medical technologies, including participation in the European EUnetHTA network. Provides systematic evaluation of new health technologies for Italian regional health authorities.
• Educazione Continua in Medicina (ECM) Program National Continuing Medical Education program management and provider support for Italian healthcare professionals, ensuring compliance with mandatory continuing education requirements.
• Portale della Trasparenza dei Servizi per la Salute (Healthcare Transparency Portal) Public-facing transparency portal providing Italian citizens with healthcare service information, waiting time data, and healthcare facility location services.

Quantifiable outcome

• Prenotations increased from 13.3 million (H1 2025) to 14.9 million (H1 2026) with over 1.6 million additional services delivered within guaranteed timeframes
• +3 more outcomes

Named customers5 records

Segments5 records

Ideal customer profiles4 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

AI capability4 records

Feature8 records

Partnerships

Twelve partnerships are on record, tiered major and core.

• Scientific Societies for Heart Team Position PapermajorStrategic or Co-development Partner · 1 January 2026Collaboration with ANMCO, GISE, ITACTAIC, SIAARTI, SIC, and SICCH for publishing Position Paper on Heart Team for multidisciplinary management of aortic valve disease. Published as Monitor 2026 supplement.
• Centro Nazionale Sangue (CNS)majorStrategic or Co-development Partner · 1 January 2026Collaboration with CNS on Patient Blood Management (PBM) in cardiac surgery - Position Paper on PBM strategies implementation, with contribution from Baxter SpA (non-conditional).
• European Commission (DG SANTE, HADEA)coreStrategic or Co-development Partner · 1 February 2023AGENAS coordinates Joint Action HEROES co-funded by the European Commission under EU4Health program. The agency maintains ongoing relationships with DG SANTE and HADEA for health workforce planning initiatives. Joint Action HEROES involves 40 partners from 19 EU/EEA countries.
• HEROES Joint Action Consortium (40 partners, 19 countries)coreStrategic or Co-development Partner · 1 February 2023Joint Action HEROES coordinated by AGENAS with partners from 19 EU/EEA countries including Hungary, Belgium, Croatia, Czech Republic, Estonia, Greece, Lithuania, Malta, Netherlands, Norway, Poland, Portugal, Romania, Slovakia, Slovenia, Spain, Sweden, and Italy. Includes 20 affiliated entities and 11 associated entities.
• FLASH Project ConsortiummajorStrategic or Co-development Partner · 1 January 2023Flexible Approaches to Support Health through financing - AGENAS is a partner focusing on hospital care financing resilience and healthcare efficiency/in quality incentives through work packages 2 and 6.
• 58 Selected Project Consortia (Progetto Grandi Anziani)majorStrategic or Co-development Partner58 projects selected from 146 applications for home care of elderly over 80, funded with 150 million EUR PNRR. Projects span 32 North area (24,937 patients), 13 Central area (17,478 patients), 13 South area (17,585 patients). Include public entities, universities, and private accredited facilities.
• Ministero della Salute (Ministry of Health)coreStrategic or Co-development PartnerAGENAS operates as technical agency under the Ministry of Health, implementing national health programs including PNRR Mission 6 Salute, conducting research, and providing technical support for health policy.
• Conferenza delle Regioni e delle P.A.coreStrategic or Co-development PartnerCollaboration with Italian Regions and Autonomous Provinces conference for healthcare coordination, standards development, and regional implementation support.
• Italian Regions (all 21)coreStrategic or Co-development PartnerDirect partnerships with all 21 Italian regions and autonomous provinces for healthcare monitoring, accreditation, training, and digital platform services.
• Agenzia Italiana del Farmaco (AIFA)majorStrategic or Co-development PartnerCollaboration on pharmaceutical policies and health technology assessment with Italy's medicines agency.
• Istituto Superiore di Sanita (ISS)majorStrategic or Co-development PartnerCollaboration on public health research, epidemiological surveillance, and health technology assessment with Italy's national health institute.
• EUnetHTA (European Network for Health Technology Assessment)majorStrategic or Co-development PartnerParticipation in European HTA collaboration and Horizon Scanning activities through EUnetHTA network.

Scale indicators11 records

Recent moves6 records

Expansion highlights5 records

Direct peers

• Haute Autorité de Santé (HAS): France's independent national health authority responsible for HTA, clinical guidelines, accreditation of healthcare organizations, and quality-of-care indicators — directly comparable to AGENAS's accreditation, HTA, and PNE outcomes-monitoring functions.
• KCE – Belgian Health Care Knowledge Centre: Belgian federal scientific research center producing HTA reports, health-services research, and clinical-guideline support — directly comparable in HTA, guideline development, and EUnetHTA participation, on a smaller national scale.
• Istituto Superiore di Sanità (ISS): Italy's national health institute conducting public-health research, epidemiological surveillance, and HTA — a listed AGENAS partner and the closest Italian institutional peer, with overlapping scope in research coordination and national health policy support.
• Zorginstituut Nederland (ZIN): Dutch national body for health insurance, quality of care, and HTA — comparable to AGENAS's mandate spanning HTA, accreditation standards, and national care-quality programs, and a co-participant in EUnetHTA.
• AIFA – Agenzia Italiana del Farmaco: Italy's national medicines agency handling pharmaceutical regulation, HTA, and pharmacovigilance — a listed AGENAS partner and direct domestic peer in the Italian health-agency ecosystem with adjacent regulatory scope.
• NICE – National Institute for Health and Care Excellence: UK national body producing clinical guidelines, HTA, quality standards, and digital-health guidance for the NHS — directly comparable to AGENAS's guideline publication (e.g., Heart Team Position Paper, teleradiology guidelines) and HTA activities.
• SBU – Swedish Agency for Health Technology Assessment and Assessment of Social Services: Sweden's national HTA agency producing systematic reviews and assessments for healthcare decision-making — directly comparable to AGENAS's HTA and Horizon Scanning activities and EUnetHTA role.

Broad incumbents

• NHS England: UK national health agency operating at the central-government tier, responsible for commissioning, performance oversight, and digital health infrastructure across England's regions — a direct comparable to AGENAS's mandate over Italy's 21 regional health systems.
• G-BA – Gemeinsamer Bundesausschuss (German Federal Joint Committee): Germany's highest decision-making body in the joint self-governance of physicians, dentists, hospitals, and insurers — broader scope than AGENAS but comparable in setting national clinical guidelines, HTA directives, and quality standards across regional providers.
• AEMPS – Agencia Española de Medicamentos y Productos Sanitarios: Spanish national agency for medicines and health products regulation, HTA, and health-services oversight — broader scope than AGENAS but operationally comparable as a centralized national health authority coordinating regional health delivery.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

• Xtwitter.com/agenas_salute
• YouTubeyoutube.com/agenas
• Facebookfacebook.com/Agenas.Salute
• LinkedInlinkedin.com/company/agenas

Revenue estimate

Valuation estimate

Number of profiles

Profiles2 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Agenas